How Can We Reach Quality And Equality?
Ageing populations, budgetary constraints and rising healthcare costs threaten the viability of national healthcare systems. Most of the medicines sold in Europe come from India and China, where production is cheapest. As a result, Europe’s supply of medicines is in the hands of a few companies. What must be done in order to avoid a shortage of key medicines and to increase the production of life-saving medicines in the wake of the coronavirus crisis? What can be done to safeguard European citizens’ access to healthcare? How can we make sure that all patients are treated equally?
Bring these and many more questions and comments to our online public debate on 15 September 2021 at 17:00 CEST with experts from legal practice, industry, and the patients community.
The debate will be opened by:
|Patricia Cappuyns, Attorney at Law, Fox IP Law, Zottegem|
|Alexander Natz, Secretary General, EUCOPE, Brussels|
|François Houÿez, Information & Access to Therapies, Director & Health Policy Advisor, EURORDIS, Rare Diseases Europe, Paris and Brussels|
|Moderator:||Florence Hartmann-Vareilles, Head of section - Business Law, ERA|
Supported by the European Union